Article

Screening for early-stage Alzheimer’s disease using optimized feature sets and machine learning

2020-10-30

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Detecting early-stage Alzheimer’s disease in clinical practice is difficult due to a lack of efficient and easily administered cognitive assessments that are sensitive to very mild impairment, a likely contributor to the high rate of undetected dementia. <h4>Objective</h4> Here, we aim to identify groups of cognitive assessment features optimized for detecting mild impairment...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1217110d-53af-58e6-94e2-b68b2f6588eb
DOI: 10.1101/2020.10.28.20212027

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Screening for early-stage Alzheimer’s disease using optimized feature sets and machine learningDOI 10.1101/2020.10.28.20212027Read

Risk Score Stratification of Alzheimer’s Disease and Mild Cognitive Impairment using Deep LearningSemantic proximity Read

Machine Learning methods for predicting conversion from mild cognitive impairment to Alzheimer’s disease. A systematic review.Semantic proximity Read

Development of Alzheimer’s Disease Risk Score for Future Primary Care: A White-Box ApproachSemantic proximity Read

Predicting 24-Month MCI-to-Alzheimer’s Conversion Using Routine Clinical Assessments Without Neuroimaging or Genetic TestingSemantic proximity Read

A Novel Ensemble-Based Machine Learning Algorithm To Predict The Conversion From Mild Cognitive Impairment To Alzheimer’s Disease Using Socio-demographic Characteristics, Clinical Information And Neuropsychological MeasuresSemantic proximity Read

Aging as an active player in Alzheimer’s Disease Classification: Insights from feature selection in BrainAge ModelsSemantic proximity Read

Developing multifactorial dementia prediction models using clinical variables from cohorts in the US and AustraliaSemantic proximity Read

A Machine Learning Approach to Predict Cognitive Decline in Alzheimer’s Disease Clinical TrialsSemantic proximity Read

Standardized Comparison of Clinical, Cognitive, Genetic, Neuroimaging, and Fluid Biomarkers for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer’s DiseaseSemantic proximity Read

Predicting future cognitive impairment in preclinical Alzheimer’s disease using multimodal imaging: a multisite machine learning studySemantic proximity Read

Comprehensive evaluation of AT(N) imaging biomarkers for predicting cognitionSemantic proximity Read

Early Alzheimer's Disease Detection with Multiple Machine Learning ModelsSemantic proximity Read